Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 433
- Locations
- 1
- Primary Endpoint
- proportion of women who were adherent to all conditionalities and received the most effective ARV intervention they were eligible to receive and delivered at an affiliated maternity
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The goals of the proposed study are to: 1) test whether small, increasing cash payments to HIV-infected pregnant women, on the condition that they attend scheduled clinic visits and receive proposed services, will increase the proportion of women who receive the most effective antiretroviral regimen they are eligible for by the time of delivery, and 2) elucidate factors that facilitate or inhibit the uptake and adherence to the PMTCT cascade, and to what extent the conditional cash payment program addresses these factors.
This intervention will be implemented and evaluated within our well-established PMTCT program in Kinshasa, Democratic Republic of Congo (DRC),
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed as HIV-positive
- •Pregnant between 28 and 32 weeks of gestation (\>27 and \<32 completed weeks of pregnancy)
- •Intend to stay in Kinshasa through delivery and six weeks postpartum
- •Able and willing to participate (provide informed consent)
Exclusion Criteria
- •Women will be excluded from the study if they are severely ill and require extended hospitalization or need to be cared for at a referral hospital out of the PMTCT network
Outcomes
Primary Outcomes
proportion of women who were adherent to all conditionalities and received the most effective ARV intervention they were eligible to receive and delivered at an affiliated maternity
Time Frame: 6 weeks postpartum
At each monthly visit starting at randomization (28 weeks), participants will be evaluated for the following conditionalities: 1. attended the scheduled visit on time (+/- 5 days) 2. accept HIV status and services proposed to them 3. return to deliver in the clinic At the end of the follow-up (6 weeks post-partum)the proportion of participants who adhered to all these conditions will be calculated for each study group
Secondary Outcomes
- Mother to child transmission rate at six weeks and HIV-free survival.(6 weeks post partum)
- Proportion of HIV-exposed infants who at their six week visit received extended Nevirapine (NVP) had a DNA PCR test(6 weeks Postpartum)
- HIV-free survival at 18 month.(18 months porstpartum)